Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

Abstract

MWA may not only be a promising local therapy but also a trigger of antitumor immunity for breast cancer, opening new avenues for the treatment of breast cancer. Combinatorial strategy using additional agents which boost MWA-induced immune response could be considered as potential treatment for clinical study for early breast cancer therapy.